Jayne B. Hart - Jun 9, 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief People Officer
Signature
By: Nathan A. Smith For: Jayne B. Hart
Stock symbol
MYGN
Transactions as of
Jun 9, 2022
Transactions value $
$15,375
Form type
4
Date filed
6/10/2022, 04:40 PM
Previous filing
Mar 25, 2022
Next filing
Aug 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $15.4K +1.04K +0.57% $14.84 183K Jun 9, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).